CNS Cancer: Clinical Trials

4 trials for CNS Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 11Completed 1

Follow CNS Cancer: new trials by email Literature Review of CNS Cancer trials Research Report on CNS Cancer

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
RVP-001 - Central Nervous System (CNS) Lesions, Brain Metastases
Phase 2CompletedReveal Pharmaceuticals Inc.182024-08-152025-12-26
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
Sunitinib - CNS Cancer, Meningioma
Phase 2CompletedMemorial Sloan Kettering Cancer Center502007-10-012016-01-25
Study of D-Methadone in Patients With Chronic Pain
d-Methadone, D-methadone, placebo - Pain, Bladder Cancer
Phase 1 / Phase 2CompletedMemorial Sloan Kettering Cancer Center102004-10-012016-08-10
Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma
temozolomide followed by high dose busulfan and thiotepa - CNS Cancer, CNS BRAIN
Phase 2CompletedMemorial Sloan Kettering Cancer Center602002-09-012023-10-27

Narrower conditions

Central Nervous System Neoplasms (4)  ·  Brain Neoplasms (2)  ·  Meningioma (2)  ·  Breast Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Eye Neoplasms (1)  ·  Glioma (1)  ·  Head and Neck Neoplasms (1)  ·  Hemangioblastoma (1)  ·  Multiple Sclerosis (1)  ·  Neoplasms (1)  ·  Neurilemmoma (1)  ·  Neurofibroma (1)  ·  Neurofibromatoses (1)

Broader conditions

Neoplasms by Site (4)  ·  Nervous System Diseases (4)  ·  Nervous System Neoplasms (4)  ·  Neoplasms (3)  ·  Otorhinolaryngologic Diseases (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cranial Nerve Diseases (2)  ·  Cranial Nerve Neoplasms (2)  ·  Ear Diseases (2)  ·  Meningeal Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neoplasms, Vascular Tissue (2)

Interventions

Busulfan (1)  ·  D-methadone (1)  ·  Mn-PyC3A (1)  ·  Sunitinib (1)  ·  Thiotepa (1)

Sponsors

Memorial Sloan Kettering Cancer Center (3)  ·  Reveal Pharmaceuticals Inc. (1)

Countries

United States (4)

Top investigators

Thomas Kaley, MD (2)  ·  Natalie Moryl, MD (1)

Results publications

PMID 28472509

NIH funding

R44CA261240 (1)